Cargando…
A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo Glioblastoma tumor growth
Anti-apoptotic members of the Bcl-2 family proteins play central roles in the regulation of cell death in glioblastoma (GBM), the most malignant type of brain tumor. Despite the advances in GBM treatment, there is still an urgent need for new therapeutic approaches. Here, we report a novel 4-thiazol...
Autores principales: | Calis, Seyma, Dogan, Berna, Durdagi, Serdar, Celebi, Asuman, Yapicier, Ozlem, Kilic, Turker, Turanli, Eda Tahir, Avsar, Timucin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617882/ https://www.ncbi.nlm.nih.gov/pubmed/36309485 http://dx.doi.org/10.1038/s41420-022-01225-9 |
Ejemplares similares
-
Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2
por: Tutumlu, Gurbet, et al.
Publicado: (2020) -
Genome-wide identification of Chiari malformation type I associated candidate genes and chromosomal variations
por: AVŞAR, Timuçin, et al.
Publicado: (2020) -
Investigation of neuro-inflammatory parameters in a cuprizone induced mouse model of multiple sclerosis
por: AVŞAR, Timucin, et al.
Publicado: (2021) -
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
por: Oakes, SR, et al.
Publicado: (2012) -
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
por: Ramesh, Prashanthi, et al.
Publicado: (2020)